Regulatory Story
Go to market news section View chart   Print
The MedicX Fund Limited  -  MXF   

MedicX enters the EPRA Europe Index

Released 09:36 18-Mar-2013

RNS Number : 2169A
The MedicX Fund Limited
18 March 2013



For immediate release

18 March 2013


MedicX Fund Limited

("MedicX Fund", "the Fund" or "the Company")


MedicX enters the EPRA Europe Index


MedicX Fund Limited (LSE: MXF), the specialist primary care infrastructure investor in modern purpose-built primary healthcare properties in the United Kingdom, announces that from today, Monday 18 March 2013, the Fund will be included in the FTSE EPRA/NAREIT Developed Europe Index. MedicX Fund passed all eligibility criteria during the Index's March Quarterly Review with an investability weight of 100%.


The EPRA Index is a widely used investment index for listed real estate. The European Index contains 86 constituents and has a market capitalisation of approximately EUR 104 billion.


Commenting on the news, Mike Adams, CEO of MedicX Group said:

"I am delighted that MedicX has been incorporated into the EPRA Europe Index. It represents our commitment to best practice, to growth and an opportunity for global investors to play a part in our ongoing success."



For further information please contact:


MedicX Group                                                                +44 (0) 1483 869 500

Keith Maddin, Chairman

Mike Adams, Chief Executive Officer

Mark Osmond, Chief Financial Officer


Buchanan                                                                     +44 (0) 20 7466 5000

Charles Ryland/Sophie McNulty/Helen Greenwood




Information on MedicX Fund Limited


MedicX Fund Limited ("MXF", the "Fund" or the "Company", or together with its subsidiaries, the "Group") is the specialist primary care infrastructure investor in modern, purpose-built primary healthcare properties in the United Kingdom, listed on the London Stock Exchange, with a portfolio comprising 107 properties.


The Investment Adviser to the Company is MedicX Adviser Ltd, which is authorised and regulated by the Financial Services Authority and is a subsidiary of the MedicX Group. The MedicX Group is a specialist investor, developer and manager of healthcare properties with 31 people operating across the UK.  


The Company's website address is  Neither the contents of the Company's website nor the contents of any website accessible from hyperlinks on the Company's website (or any other website) is incorporated into, or forms part of, this announcement.



This information is provided by RNS
The company news service from the London Stock Exchange

London Stock Exchange plc is not responsible for and does not check content on this Website. Website users are responsible for checking content. Any news item (including any prospectus) which is addressed solely to the persons and countries specified therein should not be relied upon other than by such persons and/or outside the specified countries. Terms and conditions, including restrictions on use and distribution apply.


MedicX enters the EPRA Europe Index - RNS